is dulaglutide a glp-1 How Agonists Assist in Diabetic Weight Loss Probiotics may boost effectiveness of

Patients seeking tirzepatide (Zepbound) for weight management now need either: (1) a documented Wegovy trial of 1216 weeks showing less than 5% weight loss, OR (2) documented intolerance or medical contraindication to semaglutide

There are several approaches to ongoing treatment once you have reached or are approaching your target BMI

5,21 Furthermore, 24 months treatment with the anti-osteoporotic drugs denosumab (Dmab) and alendronate in T2D lead to improvements of bone mineral density (BMD), but Dmab also induced a modest improvement in glycaemic control when compared to alendronate

fainting or feeling dizzy

Wegovy is approved by Health Canada for chronic weight management in adults with a specific BMI or weight-related health conditions